Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
7.13
-0.32 (-4.32%)
At close: May 12, 2025, 4:00 PM
7.89
+0.76 (10.69%)
After-hours: May 12, 2025, 7:28 PM EDT
Liminatus Pharma Statistics
Total Valuation
LIMN has a market cap or net worth of $185.44 million. The enterprise value is $216.94 million.
Market Cap | 185.44M |
Enterprise Value | 216.94M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
LIMN has 26.01 million shares outstanding.
Current Share Class | 26.01M |
Shares Outstanding | 26.01M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +54.23% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | -10.35 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19
Current Ratio | 0.19 |
Quick Ratio | 0.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -15.70 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 20.54% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 0.25 |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 102,162 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -3.93M |
Pretax Income | n/a |
Net Income | -4.09M |
EBITDA | n/a |
EBIT | -3.93M |
Earnings Per Share (EPS) | -$0.04 |
Balance Sheet
The company has $47,000 in cash and $19.27 million in debt, giving a net cash position of -$19.23 million or -$0.74 per share.
Cash & Cash Equivalents | 47,000 |
Total Debt | 19.27M |
Net Cash | -19.23M |
Net Cash Per Share | -$0.74 |
Equity (Book Value) | -19.11M |
Book Value Per Share | -0.17 |
Working Capital | -19.24M |
Cash Flow
Operating Cash Flow | -1.63M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LIMN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -2.07% |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |